Atea Pharmaceuticals starts dosing in late-stage COVID-19 study
29 April 2021 - 11:47PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Atea Pharmaceuticals (NASDAQ:AVIR)
Historical Stock Chart
From Apr 2024 to May 2024
Atea Pharmaceuticals (NASDAQ:AVIR)
Historical Stock Chart
From May 2023 to May 2024